BioSpace News Archive

According to the report, the global dry eye disease diagnostics & treatment market was valued at US$ 6.1 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2020 to 2030.

The world bioreactors and fermenters market is characterized with a largely consolidated business landscape and a low to moderate level of market competition, with the top five players holding for a more than around 63% of the said market in 2015, as noted by Transparency Market Research in its recent report.

Opioids are drugs which are used to treat pain which is derived from opium. Prescribed opioids are used to control chronic and high amount of pain which alter the mood and produce euphoric feelings.

Medical floor mats are introduced to provide long-lasting relief from the aches and pains from standing on hard floor surfaces and provides superior comfort to doctors, surgeons, and technicians.

The global biopharmaceutical logistics market is competitive nature with a large number of players operating worldwide, states a new research report by Transparency Market Research.

The big data in healthcare market is believed to be the future and game-changer of the healthcare sector with high adoption amongst medical professionals, government bodies, and even patients.

Mesoblast Limited announced that the Oncologic Drugs Advisory Committee of the United States Food and Drug Administration voted overwhelmingly in favor that the available data support the efficacy of remestemcel-L in pediatric patients with steroid-refractory acute graft versus host disease.

China Pharma Holdings, Inc., an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, announced financial results for the quarter ended June 30, 2020.

Microbix Biosystems Inc., an award-winning life sciences innovator and exporter, reports results for its third quarter and year to date fiscal 2020 ended June 30, 2020, with an increase of 141% in sales of Quality Assessment products.

Thirty Madison, a leading digital health company reinventing the patient experience for the estimated 133 million Americans living with chronic conditions, today announced a $47 million Seri